Supported by 32 partners from 23 countries, ERA PerMed is an ERA-NET Cofund created to align national research strategies, promote excellence, and strengthen the competitiveness of European players in personalized medicine.

Target group

The funding program is aimed at researchers working in the field of personalized medicine at universities, non-academic research institutions, and research departments in related sectors.

Funding goals

Personalized medicine (PM) represents a paradigm shift from the “one size fits all” approach to an optimized strategy for the prevention, diagnosis, and treatment of disease for each person, based on their own unique biological characteristics. Accordingly, personalized medicine puts the patient at the center of health care, aiming for optimal management of a patient’s disease and/or predisposition to disease.

Funding period and funding amount

The maximum funding period is 36 months.


The requirements and specifications for the FWF programs Principal Investigator Projects or Clinical Research apply.


Decided by the Scientific Board based on a recommendation of the Call Secretariat

Application information

No call currently in progress

Funding institution

Austrian Science Fund (FWF)


Currently no submissions

Inquiries and contact

Dr. Milojka Gindl
+43 676 83487 8209

Scroll to the top